SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-048095
Filing Date
2024-02-27
Accepted
2024-02-27 17:12:05
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d785884ds3.htm S-3 379104
2 EX-1.2 d785884dex12.htm EX-1.2 243321
3 EX-4.1 d785884dex41.htm EX-4.1 278446
4 EX-4.2 d785884dex42.htm EX-4.2 277075
5 EX-5.1 d785884dex51.htm EX-5.1 18204
6 EX-5.2 d785884dex52.htm EX-5.2 7728
7 EX-23.1 d785884dex231.htm EX-23.1 1754
8 EX-FILING FEES d785884dexfilingfees.htm EX-FILING FEES 61124
9 GRAPHIC g785884g0223080143346.jpg GRAPHIC 2642
10 GRAPHIC g785884g0226171643623.jpg GRAPHIC 2729
11 GRAPHIC g785884g54n63.jpg GRAPHIC 42635
  Complete submission text file 0001193125-24-048095.txt   1334349
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277419 | Film No.: 24688389
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)